Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

National ICD Registry: The 2008 annual report on the National ICD Registry, released by the Heart Rhythm Society and American College of Cardiology Foundation on Sept. 2, shows that total complications for new implantable cardioverter defibrillators decreased from 3.78% in 2006 to 3.01% in 2008. Primary prevention patients accounted for 78% of ICD implants. Of the patients receiving an ICD for primary prevention, 79% met the published professional guidelines. As of June, the registry has collected data from 380,000 implants in the U.S., representing over 90% of all ICDs implanted in the U.S. from 1,432 participating hospitals and 4,563 participating physicians

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel